David Snitnam

Co-Founder at Array BioPharma Inc.

David Snitnam

David Snitnam

Co-Founder at Array BioPharma Inc.

Overview
Career Highlights

Array BioPharma Inc.

RelSci Relationships

1235

Number of Boards

1

Relationships
RelSci Relationships are individuals David Snitnam likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder & General Partner at Boulder Ventures Ltd.

Relationship likelihood: Strong

Former Chief Executive Officer & Director at Array BioPharma Inc.

Relationship likelihood: Strong

Director, President & Chief Executive Officer at Atreca, Inc.

Relationship likelihood: Strong

Former Managing Partner at KPMG LLP

Relationship likelihood: Strong

Distinguished Professor of Chemistry & Biochemistry at The University of Colorado

Relationship likelihood: Strong

Venture Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Co-Founder at Array BioPharma Inc.

Relationship likelihood: Strong

President, Treasurer & Director at Array BioPharma Inc.

Relationship likelihood: Strong

Former Chief Executive Officer at Array BioPharma Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Mirati Therapeutics, Inc.

Relationship likelihood: Strong

Paths to David Snitnam
Potential Connections via
Relationship Science
You
David Snitnam
Co-Founder at Array BioPharma Inc.
Career History
Co-Founder
Current

Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO.

Boards & Committees
Director
1998 - 2012

Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO.

Transactions
Details Hidden

Array BioPharma Inc. raised money in a private placement transaction

Other Affiliations

David Snitnam is affiliated with Array BioPharma Inc., Array BioPharma Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David Snitnam. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David Snitnam's profile does not indicate a business or promotional relationship of any kind between RelSci and David Snitnam.